CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Clinical trial NCT07181720 · RECRUITING

Trial details

NCT number: NCT07181720
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma (RCC)Lung Cancer Anaplastic Thyroid Carcinomas Ovarian Cancer Cervical Cancer Thymic Carcinoma

Start date: 2025-09-12
Primary completion: 2028-03-31
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.